{"Q": 1, "answer": "no", "rationale": "The segment states the network has begun scaling up testing but does not use an intensifier or comparative with a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20472", "batch_size": 200, "batch_pos": 124, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, or other Q2 alarmist cues.", "method": "llm_batch", "batch_id": "batch_2_19076", "batch_size": 192, "batch_pos": 83, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 3, "answer": "no", "rationale": "'begun scaling up' is not a moderate verb + scale pattern. '190 sites' and '36 states' are scales, but paired with 'scaling up testing'.", "method": "llm_batch", "batch_id": "batch_3_20148", "batch_size": 200, "batch_pos": 192, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14392", "batch_size": 200, "batch_pos": 185, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 5, "answer": "no", "rationale": "Reports scaling up testing, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_8892", "batch_size": 200, "batch_pos": 179, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 6, "answer": "no", "rationale": "The segment contains numbers but not a minimiser token combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_19832", "batch_size": 200, "batch_pos": 127, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_15368", "batch_size": 200, "batch_pos": 107, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 8, "answer": "yes", "rationale": "Describes a capability/safeguard ('begun scaling up H5-specific testing') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_18524", "batch_size": 86, "batch_pos": 1, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
